UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 232

Sortiert nach

Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies

Bone marrow transplantation (Basingstoke), 2023-11, Vol.58 (11), p.1264-1266

2023

Volltextzugriff (PDF)

Protocol for a multicentre randomised controlled trial of STeroid Administration Routes For Idiopathic Sudden sensorineural Hearing loss: The STARFISH trial

PloS one, 2024-02, Vol.19 (2), p.e0290480-e0290480

2024

Volltextzugriff (PDF)

Study protocol for a randomised controlled trial to investigate the effectiveness of thoracic epidural and paravertebral blockade in reducing chronic post-thoracotomy pain: 2 (TOPIC 2)

Trials, 2023-11, Vol.24 (1), p.748-748, Article 748

2023

Volltextzugriff (PDF)

Artificial intelligence for the practical assessment of nutritional status in emergencies

Expert systems, 2024-07, Vol.41 (7), p.n/a

2024

Volltextzugriff (PDF)

Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial

Lung cancer (Amsterdam, Netherlands), 2022-09, Vol.171, p.26-33

2022

Volltextzugriff (PDF)

Young People's Transitions into Creative Work: Navigating Challenges and Opportunities

1st edition., 2020

Volltextzugriff (PDF)

Tactical network planning for food aid distribution in Kenya

Computers & operations research, 2015-04, Vol.56, p.68-83

2015

Volltextzugriff (PDF)

A new approach to multi-professional end of life care training using a sequential simulation (SqS Simulation™) design: A mixed methods study

Nurse education today, 2018-12, Vol.71, p.26-33

2018

Volltextzugriff (PDF)

Steroid-Associated Adverse Events Are Dose-Dependent Following Hematopoietic Cell Transplantation for Pediatric Hematologic Malignancies

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S339-S339

2024

Volltextzugriff (PDF)

Predicting Immune Pathology after Hematopoietic Stem Cell Transplant with Transcriptomics: Naïve CD4 T Cell Expansion at Day 100 Predicts Patients with De Novo Chronic Gvhd

Blood, 2020-11, Vol.136 (Supplement 1), p.38-39

2020

Volltextzugriff (PDF)

20 - Prospective Study of Allogeneic Pediatric Transplant Associated Thrombotic Microangiopathy-Novel Prognostic Markers, Biologic Interaction and Outcomes

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S16-S17

2023

Volltextzugriff (PDF)

Prospective Study of Allogeneic Pediatric Transplant Associated Thrombotic Microangiopathy-Novel Prognostic Markers, Biologic Interaction and Outcomes

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S16-S17

2023

Volltextzugriff (PDF)

T Stem Cell Memory Dynamics during Acute Graft-Versus-Host Disease

Blood, 2015-12, Vol.126 (23), p.3079-3079

2015

Volltextzugriff (PDF)

Mechanism of Success of Abatacept in Hematopoietic Stem Cell Transplantation: Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis Demonstrates Greater Abatacept Exposure Decreases Acute Gvhd (AGVHD) Risk without Increasing Adverse Events

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S260-S261

2023

Volltextzugriff (PDF)

341 - Mechanism of Success of Abatacept in Hematopoietic Stem Cell Transplantation: Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis Demonstrates Greater Abatacept Exposure Decreases Acute Gvhd (AGVHD) Risk without Increasing Adverse Events

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S260-S261

2023

Volltextzugriff (PDF)

Th17/Th22 Cells Mediate Breakthrough Graft-Versus-Host-Disease

Blood, 2015-12, Vol.126 (23), p.1878-1878

2015

Volltextzugriff (PDF)

Pulmonary Features of Transplant Associated Thrombotic Microangiopathy (TA-TMA)

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S144-S145

2022

Volltextzugriff (PDF)

174 - Pulmonary Features of Transplant Associated Thrombotic Microangiopathy (TA-TMA)

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S144-S145

2022

Volltextzugriff (PDF)

Early Breakthrough T Cell Proliferation Despite CNI/MTX Prophylaxis Is a Harbinger of Acute Gvhd (AGVHD) and Is Controlled By Abatacept: Mechanism of Success of the ABA2 Agvhd Prevention Trial

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S255-S256

2023

Volltextzugriff (PDF)

Abatacept for the Prevention of Graft Versus Host Disease in Pediatric Patients Receiving 7/8 HLA-Mismatched Unrelated Transplant for Hematologic Malignancies: A Real-World Analysis

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S257

2023

Volltextzugriff (PDF)

336 - Abatacept for the Prevention of Graft Versus Host Disease in Pediatric Patients Receiving 7/8 HLA-Mismatched Unrelated Transplant for Hematologic Malignancies: A Real-World Analysis

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S257-S257

2023

Volltextzugriff (PDF)

334 - Early Breakthrough T Cell Proliferation Despite CNI/MTX Prophylaxis Is a Harbinger of Acute Gvhd (AGVHD) and Is Controlled By Abatacept: Mechanism of Success of the ABA2 Agvhd Prevention Trial

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S255-S256

2023

Volltextzugriff (PDF)

Striking Clinical, Molecular and Immunological Outcomes in Non-Human Primate Hematopoietic Stem Cell Transplantation Using a Novel OX40L Blockade Agent, KY1005, Combined with Rapamycin

Blood, 2016-12, Vol.128 (22), p.3341-3341

2016

Volltextzugriff (PDF)

P1.07-015 STOMP: A UK National Cancer Research Network Randomised, Double Blind, Multicentre Phase II Trial of Olaparib as Maintenance Therapy in SCLC: Topic: Drug Treatment Alone and in Combination with Radiotherapy

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S704-S705

2017

Volltextzugriff (PDF)

1 – 25 von 232

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(185)
Mit Volltextzugriff
(203)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(122)
Life Sciences & Biomedicine
(90)
Humans
(83)
Male
(44)
Female
(43)
Social Sciences
(26)
Adult
(25)
Middle Aged
(21)
Risk Factors
(20)
Multidisciplinary Sciences
(16)
Science & Technology - Other Topics
(16)
Cell Biology
(15)
Mutation
(15)
Aged
(13)
Medicin Och Hälsovetenskap
(13)
Technology
(13)
Animals
(12)
Biochemistry & Molecular Biology
(12)
Biological And Medical Sciences
(12)
Physical Sciences
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies

Protocol for a multicentre randomised controlled trial of STeroid Administration Routes For Idiopathic Sudden sensorineural Hearing loss: The STARFISH trial

Study protocol for a randomised controlled trial to investigate the effectiveness of thoracic epidural and paravertebral blockade in reducing chronic post-thoracotomy pain: 2 (TOPIC 2)

Antidepressants for the prevention of depression following first-episode psychosis (ADEPP): study protocol for a multi-centre, double-blind, randomised controlled trial

Artificial intelligence for the practical assessment of nutritional status in emergencies

Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial

Young People's Transitions into Creative Work: Navigating Challenges and Opportunities

Tactical network planning for food aid distribution in Kenya

A new approach to multi-professional end of life care training using a sequential simulation (SqS Simulation™) design: A mixed methods study

Steroid-Associated Adverse Events Are Dose-Dependent Following Hematopoietic Cell Transplantation for Pediatric Hematologic Malignancies

Predicting Immune Pathology after Hematopoietic Stem Cell Transplant with Transcriptomics: Naïve CD4 T Cell Expansion at Day 100 Predicts Patients with De Novo Chronic Gvhd

20 - Prospective Study of Allogeneic Pediatric Transplant Associated Thrombotic Microangiopathy-Novel Prognostic Markers, Biologic Interaction and Outcomes

Prospective Study of Allogeneic Pediatric Transplant Associated Thrombotic Microangiopathy-Novel Prognostic Markers, Biologic Interaction and Outcomes

T Stem Cell Memory Dynamics during Acute Graft-Versus-Host Disease

Mechanism of Success of Abatacept in Hematopoietic Stem Cell Transplantation: Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis Demonstrates Greater Abatacept Exposure Decreases Acute Gvhd (AGVHD) Risk without Increasing Adverse Events

341 - Mechanism of Success of Abatacept in Hematopoietic Stem Cell Transplantation: Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis Demonstrates Greater Abatacept Exposure Decreases Acute Gvhd (AGVHD) Risk without Increasing Adverse Events

Th17/Th22 Cells Mediate Breakthrough Graft-Versus-Host-Disease

Pulmonary Features of Transplant Associated Thrombotic Microangiopathy (TA-TMA)

174 - Pulmonary Features of Transplant Associated Thrombotic Microangiopathy (TA-TMA)

Early Breakthrough T Cell Proliferation Despite CNI/MTX Prophylaxis Is a Harbinger of Acute Gvhd (AGVHD) and Is Controlled By Abatacept: Mechanism of Success of the ABA2 Agvhd Prevention Trial

Abatacept for the Prevention of Graft Versus Host Disease in Pediatric Patients Receiving 7/8 HLA-Mismatched Unrelated Transplant for Hematologic Malignancies: A Real-World Analysis

336 - Abatacept for the Prevention of Graft Versus Host Disease in Pediatric Patients Receiving 7/8 HLA-Mismatched Unrelated Transplant for Hematologic Malignancies: A Real-World Analysis

334 - Early Breakthrough T Cell Proliferation Despite CNI/MTX Prophylaxis Is a Harbinger of Acute Gvhd (AGVHD) and Is Controlled By Abatacept: Mechanism of Success of the ABA2 Agvhd Prevention Trial

Striking Clinical, Molecular and Immunological Outcomes in Non-Human Primate Hematopoietic Stem Cell Transplantation Using a Novel OX40L Blockade Agent, KY1005, Combined with Rapamycin

P1.07-015 STOMP: A UK National Cancer Research Network Randomised, Double Blind, Multicentre Phase II Trial of Olaparib as Maintenance Therapy in SCLC: Topic: Drug Treatment Alone and in Combination with Radiotherapy

Suchergebnisse filtern